ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2902

The Health Status of Patients with Juvenile Idiopathic Arthritis (JIA) Significantly Worsens after Transfer from Pediatric to Adult Care

Kirsten Minden1, Jens Klotsche2, Martina Niewerth2, Angela Zink3 and Gerd Horneff4, 1Chidlrens´ hospital, Charité University Medicine, Berlin, Germany, 2Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, 3German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 4Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: DMARDs, Health Care, juvenile idiopathic arthritis (JIA) and patient outcomes, Transition

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Miscellaneous Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

A minority of patients with polyarticular JIA enter adulthood in drug free remission. Thus, patients are in need of care beyond adolescence. There is little information how patients´ health status changes after discharge from pediatric care. We therefore investigated changes in the patients´ health status before and after the transfer from pediatric to adult health care.

Methods

Data from patients were considered who were prospectively followed in the JIA biologic register BiKeR and in the follow-up register JuMBO for at least two additional years. Disease activity (physicians´ global assessment on a numerical rating scale 0-10 [NRS]) and patient-reported outcomes (PROs; i.e. global assessment of disease activity, pain, overall well-being on NRS, functional status by CHAQ/HAQ) were assessed from inclusion in BiKeR up to the last follow-up in JuMBO.

Results

The eligible 654 patients were enrolled in BiKeR with a mean disease duration of 5.6 years (ys) at the start of a biologic (66.8%) or non-biologic DMARD (33.2%). The whole observation period of patients comprised 8.2 ys. During the years (mean 2.6) in pediatric care, i.e. from enrollment until the last visit in BiKeR, all PROs significantly improved: overall well-being from 4.5 to 2.1 (mean), pain level from 4.6 to 1.9, functional status (CHAQ-score) from 0.75 to 0.35. In contrast to this trend towards a steady improvement in patients´ health state in pediatric care, PROs significantly worsened after discharge from pediatric care (p < 0.001). At the last follow-up in JuMBO, when patients were at the age of 23 ys (mean) and had a disease duration of 14.2 ys, the mean disease activity was 2.6, pain level 2.8, and overall well-being 2.9. At that time, more patients had an active disease (NRS>0; 71 vs. 57%) and reported pain (78 vs. 56%) and restrictions in overall well-being (86 vs. 58%) than at the last visit in pediatric care.

Adult health care providers rated the patients´ disease activity at first documentation in JuMBO lower than pediatric rheumatologists at the last visit in pediatric rheumatology care (1.8 vs. 2.1), which is in contrast to patients´ self-reports. They also rated the disease activity lower than the patients did at last observation in JuMBO (1.9 vs. 2.6). The correlation between physician and patient scores for disease activity was better during pediatric than adult care (0.56 vs. 0.51).

Conclusion

The health state of patients with long-standing JIA significantly worsens after discharge from pediatric care. The reasons for this have to be explored. In addition, there are larger discrepancies between physician- and patient-reported outcomes in adult care than in pediatric care.


Disclosure:

K. Minden,
None;

J. Klotsche,
None;

M. Niewerth,
None;

A. Zink,
None;

G. Horneff,

AbbVie, Pfizer, and Roche ,

2,

AbbVie, Novartis, Pfizer, and Roche,

8.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-health-status-of-patients-with-juvenile-idiopathic-arthritis-jia-significantly-worsens-after-transfer-from-pediatric-to-adult-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology